ArticleScientific reports2026
A minimal-net CNN model for an IoT-based brain tumor detection and monitoring system.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we propose M-Net, a lightweight Convolutional Neural Network (L-CNN) designed for real-time brain tumor classification and detection. Large, state-of-the-art (SOTA) CNN models often face deployment challenges on edge devices due to their high computational resource requirements. To address this, M-Net utilizes a sequential architecture with 4 × 4 kernels and progressive filter expansion, balancing computational efficiency and classification performance. The model was trained and tested on three diverse MRI datasets (3-class, 4-class, and 15-class) to evaluate its robustness and generalizability across varying brain tumor modalities. In k-fold cross-validation (k = 5) and on an unseen test set, M-Net achieved an average accuracy of 99%, outperforming SOTA CNNs (96%). The study also integrates explainable AI techniques-LIME, SHAP, and Grad-CAM-to visualize regions of MRI images contributing to the model's decision-making process. Additionally, a web and mobile application for smart brain tumor management (SBTM) was developed using M-Net, demonstrating real-time processing at 1 FPS, minimal thermal consumption, and low energy usage. The novel contributions of M-Net lie in its efficient architecture and integration with XAI, making it a suitable candidate for clinical deployment in brain tumor diagnosis. With only 495,972 parameters, M-Net offers a practical, deployable solution for real-time tumor classification on edge devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.